Trial site
Algemeen Ziekenhuis Damiaan Oostende
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease4 trials
- Stroke4 trials
- Type 2 diabetes3 trials
- Ulcerative colitis3 trials
- Colorectal cancer2 trials
- Chronic kidney disease1 trial
- Endometrial cancer1 trial
- Hepatitis B1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 28 trials
- Phase 36 trials
- Phase 43 trials
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Not yet recruiting3 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- AbbVie1 trial
- AbbVie Deutschland GmbH & Co. KG1 trial
- Antwerp University Hospital1 trial
- Bayer1 trial
- and 9 more
Running trials
Not yet recruiting
Recruiting
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections
Active, not recruiting
Recruiting
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Completed
Recruiting
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Ulcerative colitis2 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Obesity1 recruiting
- Prostate cancer1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026